245 related articles for article (PubMed ID: 17702251)
21. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
Odds FC; Bernaerts R
J Clin Microbiol; 1994 Aug; 32(8):1923-9. PubMed ID: 7989544
[TBL] [Abstract][Full Text] [Related]
22. Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32C.
Fricker-Hidalgo H; Lebeau B; Kervroedan P; Faure O; Ambroise-Thomas P; Grillot R
Ann Biol Clin (Paris); 1995; 53(4):221-5. PubMed ID: 7574109
[TBL] [Abstract][Full Text] [Related]
23. Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates.
Baumgartner C; Freydiere AM; Gille Y
J Clin Microbiol; 1996 Feb; 34(2):454-6. PubMed ID: 8789038
[TBL] [Abstract][Full Text] [Related]
24. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting.
Meyer W; Latouche GN; Daniel HM; Thanos M; Mitchell TG; Yarrow D; Schönian G; Sorrell TC
Electrophoresis; 1997 Aug; 18(9):1548-59. PubMed ID: 9378120
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of Agar Candida ID2 (bioMerieux) a chromogenic medium for yeasts differentiation].
Ciok-Pater E; Zalas P; Gospodarek E
Med Dosw Mikrobiol; 2006; 58(3):247-51. PubMed ID: 17341000
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of different methods for species identification of genus Candida].
López C; Giro L; Ramos L; Ramadán S; Bulacio L
Rev Argent Microbiol; 2005; 37(1):16-21. PubMed ID: 15991475
[TBL] [Abstract][Full Text] [Related]
27. Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species.
Madhavan P; Jamal F; Chong PP; Ng KP
Trop Biomed; 2011 Aug; 28(2):269-74. PubMed ID: 22041745
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis.
Cárdenes-Perera CD; Torres-Lana A; Alonso-Vargas R; Moragues-Tosantas MD; Pontón-San Emeterio J; Quindós-Andrés G; Arévalo-Morales MP
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):219-21. PubMed ID: 15541609
[TBL] [Abstract][Full Text] [Related]
29. [Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium].
Gültekin B; Yazici V; Aydin N
Mikrobiyol Bul; 2005 Jul; 39(3):319-24. PubMed ID: 16358491
[TBL] [Abstract][Full Text] [Related]
30. Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species.
Latouche GN; Daniel HM; Lee OC; Mitchell TG; Sorrell TC; Meyer W
J Clin Microbiol; 1997 Dec; 35(12):3171-80. PubMed ID: 9399515
[TBL] [Abstract][Full Text] [Related]
31. Use of chromogenic tube and methyl blue-sabouraud agar for the identification of Candida albicans strains.
Yücesoy M; Esen N; Yuluğ N
Kobe J Med Sci; 2001 Aug; 47(4):161-7. PubMed ID: 11733655
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a reformulated CHROMagar Candida.
Jabra-Rizk MA; Brenner TM; Romagnoli M; Baqui AA; Merz WG; Falkler WA; Meiller TF
J Clin Microbiol; 2001 May; 39(5):2015-6. PubMed ID: 11326038
[TBL] [Abstract][Full Text] [Related]
33. A comparison of methods for yeast identification including CHROMagar Candida, Vitek system YBC and a traditional biochemical method.
Huang LU; Chen CH; Chou CF; Lu JJ; Chi WM; Lee WH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Oct; 64(10):568-74. PubMed ID: 11791943
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and phenotypic evaluation of Candida dubliniensis in pregnant women with vulvovaginal candidosis in a university hospital in Ankara.
Us E; Cengiz SA
Mycoses; 2007 Jan; 50(1):13-20. PubMed ID: 17302742
[TBL] [Abstract][Full Text] [Related]
35. [Esterase activities of Candida species].
Keçeli SA; Budak F
Mikrobiyol Bul; 2004; 38(1-2):99-103. PubMed ID: 15293908
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of CHROMagar Candida medium for the isolation and direct identification of yeast species from the female genital tract.
Anson JJ; Allen KD
Br J Biomed Sci; 1997 Dec; 54(4):237-9. PubMed ID: 9624731
[TBL] [Abstract][Full Text] [Related]
37. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species.
Baires-Varguez L; Cruz-García A; Villa-Tanaka L; Sánchez-García S; Gaitán-Cepeda LA; Sánchez-Vargas LO; Quindós G; Hernández-Rodríguez C
Rev Iberoam Micol; 2007 Jun; 24(2):148-51. PubMed ID: 17604435
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness and efficacy of CHROMagar Candida medium in clinical specimens.
Momani OM
East Mediterr Health J; 2000; 6(5-6):968-78. PubMed ID: 12197356
[TBL] [Abstract][Full Text] [Related]
39. Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.
Horvath LL; Hospenthal DR; Murray CK; Dooley DP
J Clin Microbiol; 2003 Jun; 41(6):2629-32. PubMed ID: 12791890
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 5 new media containing extracts of seeds applied to Candida dubliniensis screening.
Loreto ES; Bolzan AR; Linares CE; Boff E; Santurio JM; Alves SH
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):191-3. PubMed ID: 16545931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
